The document is an intimation to the stock exchanges (BSE Limited and National Stock Exchange of India Limited) regarding a scheduled Analyst/Institutional Investor meeting.
The type of event is a One-on-One meeting.
The meeting is scheduled to be held on 29th May, 2026.
The meeting will be an In-person meeting.
The participant from the investor side is SBI Mutual Fund.
The location of the meeting is Mumbai.
The disclosure is made with reference to the relevant provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company has stated that the schedule is subject to change due to exigencies on the part of the Investor or the Company.
The intimation is signed by Manish Narang, President – Legal, Company Secretary & Compliance Officer of Alkem Laboratories Limited.
The document does not indicate that any unpublished price sensitive information (UPSI) will be shared, nor does it mention the availability of any presentation, transcript, or recording.
Additional Notes Section
The document is a formal compliance letter addressed to the exchanges.
No financial highlights, guidance references, or presentation summaries are included in this announcement.
No financial data or operational metrics were disclosed.
